Longevity Funder Profile

Consortium canadien en neurodégénérescence associée au vieillissement

Consortium canadien en neurodégénérescence associée au vieillissement appears in public funding acknowledgements connected to longevity publications indexed by immortal.life.

Independent source-backed profile · CA

Consortium canadien en neurodégénérescence associée au vieillissement appears in public funding acknowledgements connected to longevity publications indexed by immortal.life.

Also known as: Consortium canadien sur la neurodégénérescence associée au viellissement · CCNA · Canadian Consortium on Neurodegeneration in Aging · CCNV

Official website OpenAlex identity record ROR identity record Wikidata record

3Award entitiesView evidence →2Linked publicationsView evidence →2Longevity topicsView evidence →9UniversitiesView evidence →

Indexed publication history

How the source-linked activity changed

Filter Funding Radar

20231 publications · 2 awards

20261 publications · 2 awards

Longevity topics

Where this funder appears

17α-estradiol2 publications · 2 award entities Adipose-tissue ageing2 publications · 2 award entities

Research affiliations

Universities connected through publications

Institut universitaire de cardiologie et de pneumologie de QuébecCanada · 2 publications Linköping UniversitySweden · 2 publications Rotman Research InstituteCanada · 2 publications UCL Queen Square Institute of NeurologyUnited Kingdom · 2 publications Université LavalCanada · 2 publications University College LondonUnited Kingdom · 2 publications University of GothenburgSweden · 2 publications University of TorontoCanada · 2 publications University of Wisconsin–MadisonUnited States · 2 publications

Source records

Funding acknowledgements and linked publications

163902

Source-linked funding acknowledgement

2 linked publications · latest February 1, 2026

Distinct alterations of adiponectin, fibroblast growth factor 21 (FGF‐21), and insulin‐like growth factor binding protein 2 (IGFBP‐2) link dysmetabolism with cognitive decline across the Alzheimer's disease spectrum Steroid hormones: risk and resilience in women’s Alzheimer disease

Verify in OpenAlex →

CAN-163902

Source-linked funding acknowledgement

1 linked publication · latest February 1, 2026

Distinct alterations of adiponectin, fibroblast growth factor 21 (FGF‐21), and insulin‐like growth factor binding protein 2 (IGFBP‐2) link dysmetabolism with cognitive decline across the Alzheimer's disease spectrum

Verify in OpenAlex →

CCNA 049-04

Source-linked funding acknowledgement

1 linked publication · latest June 16, 2023

Steroid hormones: risk and resilience in women’s Alzheimer disease

Verify in OpenAlex →